HIV Citations List: October, 2015
PubMed Citations
1. Synthetic Galactomannans with Potent anti-HIV Activity. Budragchaa, D., S. Bai, T. Kanamoto, H. Nakashima, S. Han, and T. Yoshida. Carbohydrate Polymers, 2015. 130: p. 233-242. PMID[26076622].
[PubMed]. HIV_10_2015.
2. Lipophilic Prodrugs of Nucleoside Triphosphates as Biochemical Probes and Potential Antivirals. Gollnest, T., T.D. de Oliveira, D. Schols, J. Balzarini, and C. Meier. Nature Communications, 2015. 6: p. 8716. PMID[26503889].
[PubMed]. HIV_10_2015.
3. Potent Inhibitors Active against HIV Reverse Transcriptase with K101p, a Mutation Conferring Rilpivirine Resistance. Gray, W.T., K.M. Frey, S.B. Laskey, A.C. Mislak, K.A. Spasov, W.G. Lee, M. Bollini, R.F. Siliciano, W.L. Jorgensen, and K.S. Anderson. ACS Medicinal Chemistry Letters, 2015. 6(10): p. 1075-1079. PMID[26487915].
[PubMed]. HIV_10_2015.
4. Discovery of 2-pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors. Raheem, I.T., A.M. Walji, D. Klein, J.M. Sanders, D.A. Powell, P. Abeywickrema, G. Barbe, A. Bennet, S.D. Clas, D. Dubost, M. Embrey, J. Grobler, M.J. Hafey, T.J. Hartingh, D.J. Hazuda, M.D. Miller, K.P. Moore, N. Pajkovic, S. Patel, V. Rada, P. Rearden, J.D. Schreier, J. Sisko, T.G. Steele, J.F. Truchon, J. Wai, M. Xu, and P.J. Coleman. Journal of Medicinal Chemistry, 2015. 58(20): p. 8154-8165. PMID[26397965].
[PubMed]. HIV_10_2015.
5. Quantitative Structure-cytotoxicity Relationship of Oleoylamides. Sakagami, H., Y. Uesawa, M. Ishihara, H. Kagaya, T. Kanamoto, S. Terakubo, H. Nakashima, K. Takao, and Y. Sugita. Anticancer Research, 2015. 35(10): p. 5341-51. PMID[26408695].
[PubMed]. HIV_10_2015.
6. Design, Synthesis, and Biological Evaluation of 1,2-dihydroisoquinolines as HIV-1 Integrase Inhibitors. Tandon, V., Urvashi, P. Yadav, S. Sur, S. Abbat, V. Tiwari, R. Hewer, M.A. Papathanasopoulos, R. Raja, A.C. Banerjea, A.K. Verma, S. Kukreti, and P.V. Bharatam. ACS Medicinal Chemistry Letters, 2015. 6(10): p. 1065-1070. PMID[26487913].
[PubMed]. HIV_10_2015.
7. PLGA-PEG Nanoparticles Coated with anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral Spread. Tang, X., Y. Liang, X. Liu, S. Zhou, L. Liu, F. Zhang, C. Xie, S. Cai, J. Wei, Y. Zhu, and W. Hou. Nanoscale Research Letters, 2015. 10(1): p. 413. PMID[26489856].
[PubMed]. HIV_10_2015.
8. Synthesis of 6-Benzyl-1-[(benzyloxy)methyl]-3-hydroxy-5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione. Tang, X.W., L. Zhang, J.X. Zhao, Y. Zhang, Y. Guo, Z.L. Zhang, C. Tian, X.W. Wang, and J.Y. Liu. Beijing Da Xue Xue Bao, 2015. 47(5): p. 838-841. PMID[26474627].
[PubMed]. HIV_10_2015.
9. Quantitative Structure-cytotoxicity Relationship of 3-Styryl-2H-chromenes. Uesawa, Y., H. Sakagami, M. Ishihara, H. Kagaya, T. Kanamoto, S. Terakubo, H. Nakashima, H. Yahagi, K. Takao, and Y. Sugita. Anticancer Research, 2015. 35(10): p. 5299-307. PMID[26408690].
[PubMed]. HIV_10_2015.
ISI Web of Knowledge Citations
10. Synthesis and Biological Evaluation of New Eugenol Mannich Bases as Promising Antifungal Agents. Abrao, P., R. Pizi, T. de Souza, N. Silva, A. Fregnan, F. Silva, L. Coelho, L. Malaquias, A. Dias, D. Dias, M. Veloso, and D. Carvalho. Chemical Biology & Drug Design, 2015. 86(4): p. 459-465. PMID[25556966].
[WOS]. HIV_10_2015.
11. A Multiple siRNA-based anti-HIV/SHIV Microbicide Shows Protection in Both in Vitro and in Vivo Models. Boyapalle, S., W. Xu, P. Raulji, S. Mohapatra, and S. Mohapatra. Plos One, 2015. 10(9): e0135288. PMID[26407080].
[WOS]. HIV_10_2015.
12. Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection. Castellano, L., S. Bart, V. Holmes, D. Weissman, and J. Shorter. Chemistry & Biology, 2015. 22(8): p. 1074-1086. PMID[26256479].
[WOS]. HIV_10_2015.
13. Il-37 Inhibits HIV-1 Replication in Human T-cells. Chattergoon, M.A., N. Sangal, and A. Cox. Cytokine, 2015. 76(1): p. 108-108. ISI[000361862400236].
[WOS]. HIV_10_2015.
14. Ethnomedicinal Plants Used by Traditional Healers in the Management of HIV/AIDS Opportunistic Diseases in Rundu, Kavango East Region, Namibia. Chinsembu, K., A. Hijarunguru, and A. Mbangu. South African Journal of Botany, 2015. 100: p. 33-42. ISI[000361254700006].
[WOS]. HIV_10_2015.
15. Editing CCR5: A Novel Approach to HIV Gene Therapy. Cornu, T., C. Mussolino, K. Bloom, and T. Cathomen. Gene Therapy for HIV and Chronic Infections, 2015. 848: p. 117-130. PMID[25757618].
[WOS]. HIV_10_2015.
16. PML-dependent Inhibition of HIV-1 Reverse-transcription by Daxx. Dutrieux, J., G. Maarifi, D. Portilho, N. Arhel, M. Chelbi-Alix, and S. Nisole. Cytokine, 2015. 76(1): p. 68-68. ISI[000361862400053].
[WOS]. HIV_10_2015.
17. Synthesis and Biological Evaluation of a Series of 2-((1-Substituted-1H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3H)-one as Potential HIV-1 Inhibitors. Fang, Z., D. Kang, L. Zhang, B. Huang, H. Liu, C. Pannecouque, E. De Clercq, P. Zhan, and X. Liu. Chemical Biology & Drug Design, 2015. 86(4): p. 614-618. PMID[25626467].
[WOS]. HIV_10_2015.
18. Synthesis of Novel (2E)-1-[4-(2,4-Difluorophenyl)phenyl]3-arylprop-2-en-1-ones: Investigation on Spectral, Antibacterial, Molecular Docking and Theoretical Studies. Fathimunnisa, M., H. Manikandan, and S. Selvanayagam. Journal of Molecular Structure, 2015. 1099: p. 407-418. ISI[000360870400052].
[WOS]. HIV_10_2015.
19. Isolation and Anticancer, Anthelminthic, and Antiviral (HIV) Activity of Acylphloroglucinols, and Regioselective Synthesis of Empetrifranzinans from Hypericum roeperianum. Fobofou, S., K. Franke, G. Sanna, A. Porzel, E. Bullita, P. La Colla, and L. Wessjohann. Bioorganic & Medicinal Chemistry, 2015. 23(19): p. 6327-6334. PMID[26358281].
[WOS]. HIV_10_2015.
20. A Resveratrol Analog Termed 3,3,4,4,5,5-hexahydroxy-trans-stilbene is a Potent HIV-1 Inhibitor. Han, Y.S., P.K. Quashie, T. Mesplede, H.T. Xu, Y.D. Quan, W. Jaeger, T. Szekeres, and M.A. Wainberg. Journal of Medical Virology, 2015. 87(12): p. 2054-2060. ISI[000362453700012].
[WOS]. HIV_10_2015.
21. Anti-HIV Terpenoids from Daphne aurantiaca Diels. Stems. Huang, S.Z., X. Zhang, Q.Y. Ma, Y.T. Zheng, H.F. Dai, Q. Wang, J. Zhou, and Y.X. Zhao. RSC Advances, 2015. 5(98): p. 80254-80263. ISI[000362409800021].
[WOS]. HIV_10_2015.
22. Synthesis of Novel Spiro[indol-2,2-pyrroles] Using Isocyanide-based Multicomponent Reaction. Jalli, V., S. Krishnamurthy, H. Kawasaki, T. Moriguchi, and A. Tsuge. Synthetic Communications, 2015. 45(19): p. 2216-2226. ISI[000361564800006].
[WOS]. HIV_10_2015.
23. Synthesis and Preliminary Antiviral Activities of Piperidine-substituted Purines against HIV and Influenza A/H1N1 Infections. Kang, D.,Z. Fang, B. Huang, L. Zhang, H. Liu, C. Pannecouque, L. Naesens, E. De Clercq, P. Zhan, and X. Liu. Chemical Biology & Drug Design, 2015. 86(4): p. 568-577. PMID[25600073].
[WOS]. HIV_10_2015.
24. The Synthesis of Novel 5-Deoxy-3,5,5-trifluoro-apiosyl nucleoside phosphonic acid Analogs as Antiviral Agents. Kim, S. and J.H. Hong. Bulletin of the Korean Chemical Society, 2015. 36(10): p. 2484-2493. ISI[000362749900013].
[WOS]. HIV_10_2015.
25. IFN-induced factors with anti-HIV activity. Malim, M. Cytokine, 2015. 76(1): p. 59-59. ISI[000361862400015].
[WOS]. HIV_10_2015.
26. The (5Z)-5-Pentacosenoic and 5-Pentacosynoic acids Inhibit the HIV-1 Reverse Transcriptase. Moreira, L.,E. Orellano, K. Rosado, R. Guido, A. Andricopulo, G. Soto, J. Rodriguez, D. Sanabria-Rios, and N. Carballeira. Lipids, 2015. 50(10): p. 1043-1050. PMID[26345647].
[WOS]. HIV_10_2015.
27. Anti-HIV-1 Integrase Activity and Molecular Docking of Compounds from Albizia procera Bark. Panthong, P., K. Bunluepuech, N. Boonnak, P. Chaniad, S. Pianwanit, C. Wattanapiromsakul, and S. Tewtrakul. Pharmaceutical Biology, 2015. 53(12): p. 1861-1866. PMID[25868621].
[WOS]. HIV_10_2015.
28. A Concise Synthesis of (+)-Batzelladine B from Simple Pyrrole-based Starting Materials. Parr, B., C. Economou, and S. Herzon. Nature, 2015. 525(7570): p. 507-510. PMID[26375010].
[WOS]. HIV_10_2015.
29. Redoxal, an Inhibitor of de Novo Pyrimidine Biosynthesis, Augments APOBEC3G Antiviral Activity against Human Immunodeficiency Virus Type 1. Pery, E.,A. Sheehy, N. Nebane, V. Misra, M. Mankowski, L. Rasmussen, E. White, R. Ptak, and D. Gabuzda. Virology, 2015. 484: p. 276-287. PMID[26141568].
[WOS]. HIV_10_2015.
30. Antiviral Properties from Plants of the Mediterranean Flora. Sanna, G., P. Farci, B. Busonera, G. Murgia, P. La Colla, and G. Giliberti. Natural Product Research, 2015. 29(22): p. 2065-2070. PMID[25613403].
[WOS]. HIV_10_2015.
31. Synthesis and Antiviral Evaluation of 2',3'-Dideoxy-2',3'-difluoro-D-arabinofuranosyl 2,6-disubstituted purine Nucleosides. Schinazi, R.F., G.G. Sivets, M.A. Detorio, T.R. McBrayer, T. Whitaker, S.J. Coats, and F. Amblard. Heterocyclic Communications, 2015. 21(5): p. 315-327. ISI[000362568300012].
[WOS]. HIV_10_2015.
32. Stellettapeptins A and B, HIV-inhibitory Cyclic Depsipeptides from the Marine Sponge Stelletta Sp. Shin, H.J., M.A. Rashid, L.K. Cartner, H.R. Bokesch, J.A. Wilson, J.B. McMahon, and K.R. Gustafson. Tetrahedron Letters, 2015. 56(40): p. 5482-5482. ISI[000362533900027].
[WOS]. HIV_10_2015.
33. Optimized Synthesis of 3'-O-aminothymidine and Evaluation of its Oxime Derivative as an anti-HIV Agent. Solyev, P.N., M.V. Jasko, T.A. Martynova, L.B. Kalnina, D.N. Nosik, and M.K. Kukhanova. Heterocyclic Communications, 2015. 21(5): p. 291-295. ISI[000362568300009].
[WOS]. HIV_10_2015.
34. Inhibition of HIV Infection by Caerin 1 Antimicrobial Peptides. Van Compernolle, S., P. Smith, J. Bowie, M. Tyler, D. Unutmaz, and L. Rollins-Smith. Peptides, 2015. 71: p. 296-303. PMID[26026377].
[WOS]. HIV_10_2015.
35. Pyrimidine sulfonylacetanilides with Improved Potency against Key Mutant Viruses of HIV-1 by Specific Targeting of a Highly Conserved Residue. Wan, Z., J. Yao, T. Mao, X. Wang, H. Wang, W. Chen, H. Yin, F. Chen, E. De Clercq, D. Daelemans, and C. Pannecouque. European Journal of Medicinal Chemistry, 2015. 102: p. 215-222. PMID[26276435].
[WOS]. HIV_10_2015.
36. Inhibition of HIV-1 Assembly by Coiled-coil Domain Containing Protein 8 in Human Cells. Wei, M., X. Zhao, M. Liu, Z. Huang, Y. Xiao, M.J. Niu, Y.M. Shao, and L. Kleiman. Scientific Reports, 2015. (14724): 12pp. ISI[000362094500001].
[WOS]. HIV_10_2015.
37. Multistage Virtual Screening and Identification of Novel HIV-1 Protease Inhibitors by Integrating SVM, Shape, Pharmacophore and Docking Methods. Wei, Y., J. Li, Z. Chen, F. Wang, W. Huang, Z. Hong, and J. Lin. European Journal of Medicinal Chemistry, 2015. 101: p. 409-418. PMID[26185005].
[WOS]. HIV_10_2015.
38. Identification of an HIV-1 Replication Inhibitor Which Rescues Host Restriction Factor APOBEC3G in Vif-APOBEC3G Complex. Zhang, S., L. Zhong, B. Chen, T. Pan, X. Zhang, L. Liang, Q. Li, Z. Zhang, H. Chen, J. Zhou, H. Luo, H. Zhang, and C. Bai. Antiviral Research, 2015. 122: p. 20-27. PMID[26241003].
[WOS]. HIV_10_2015.
Patent Citations
39. Preparation of Phenoxypyrimidinylmethylpyridazinylmethyl dihydrogen phosphates as Prodrugs of HIV Reverse Transcriptase Inhibitors. Burgey, C.S., J.F. Fritzen, J. Balsells, and M. Patel. Patent. 2015. 2015-US22868 2015153304: 59pp.
[Patent]. HIV_10_2015.
40. Preparation of 4'-Substituted nucleoside Derivatives as HIV Reverse Transcriptase Inhibitor. Girijavallabhan, V.M., D.B. Olsen, Z. Zhang, J. Fu, and B.-Y. Tang. Patent. 2015. 2015-US22621 2015148746: 127pp.
[Patent]. HIV_10_2015.
41. Small Molecule Inhibitors of gp120-Mediated HIV Infection and Methods of Use. Lingwood, C., M. Huesca, R. Dayam, and S. Singh. Patent. 2015. 2015-CA171 2015143535: 67pp.
[Patent]. HIV_10_2015.
42. Preparation of Thienopyrimidine Derivatives and for Treating HIV Infection. Liu, X., D. Kang, P. Zhan, Z. Fang, and Z. Li. Patent. 2015. 2015-10309662 104926829: 27pp.
[Patent]. HIV_10_2015.
43. Antiviral Water-soluble Product with anti-HIV Effect, Based on Ionic Silver and Methylene Blue Compound; Method of Its Production and Examples of HIV-infected Patients' Treatment. Svetlik, H.E., V.V. Tretiakov, O.V. Tretiakova, V.N. Silnikov, V.I. Bouroumov, and N.G. Zhevachevsky. Patent. 2015. 2015-14680577 20150291542: 6pp.
[Patent]. HIV_10_2015.